Clinical trial · Observational
Sample Collection From Melanoma Patients
Blood and Tumor Sample Collection From Patients With Malignant Melanoma for Long Term Storage
NCT00507325CI-TRIAL-00060665terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Per PI
Summary
Brief summary (as posted)
The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Sample | Procedure | — | UNRESOLVED |
| Tumor Sample | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Blood Sample + Tumor Sample
- description
- Blood samples will be collected. Tumor samples will be collected using a small needle, a punch knife, or a small surgery.
- interventionNames
- Procedure: Blood Sample
- Procedure: Tumor Sample
Primary outcomes (1)
- measure
- Collection and long-term collection of blood and tumor samples from patients with malignant melanoma for future biological and/or surrogate marker studies.
- timeFrame
- 6 Years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Patients with a suspected or confirmed diagnosis of malignant melanoma. These include patients with melanoma of the soft part, spindle-cell neoplasm consistent with melanoma and choroidal melanoma. 2. Patients who are willing to consent for this protocol. Exclusion Criteria: None
References
Publications (0)
Data not yet available
No reference posted for this study.